En Es
Categories

Industry News


Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions

By Medimaging International staff writers
13 Aug 2019

Image: The CorPath GRX system (Photo courtesy of Corindus).Siemens Healthineers AG (Erlangen, Germany) has entered into a merger agreement with Corindus Vascular Robotics, Inc. (Boston, MA. USA) to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.

Corindus develops, produces and sells robotic systems for minimally invasive procedures. These systems help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is therefore, less exposed to radiation.

Siemens Healthineers’ acquisition of Corindus meets its objective of simplifying today's challenges in everyday hospital life. Robotic assisted minimally invasive procedures have the potential to reduce treatment times, increase precision during treatment, raise standardization levels in clinical procedures and ultimately improve clinical outcomes, which is the strategic focus of Siemens Healthineers’ Advanced Therapies business segment.

The CorPath systems developed by Corindus will be used along with angiography systems sold by Siemens Healthineers that make minimally invasive treatment possible by using high-quality imaging before and during medical interventions. The company's role in image-based minimally invasive procedures is now complemented by robotic-assisted precision medicine. This expansion strengthens Siemens Healthineers’ therapy position and underlines its role as one of the leading providers of solutions along the entire treatment path. The acquisition of Corindus marks a strategically significant extension of Siemens Healthineers’ therapy business.

The future integration of Siemens Healthineers’ digitization and artificial intelligence solutions with Corindus' robotic systems offers further promising possibilities. The aim is to further increase procedure optimization in order to enable the greatest possible degree of efficiency and clinical reproducibility. Additionally, Corindus is driving forward the approval procedure for remote robotic treatment in vascular interventions. Due to the limited availability of specialists for minimally invasive procedures in many regions and the limited number of corresponding clinical facilities, remote treatment could significantly improve patients' access to treatment in the future.

“Together with Corindus, Siemens Healthineers is well-positioned to be one of the leading players in the field of robotic vascular interventions and to perform minimally invasive procedures more accurately, more quickly and more effectively. With this acquisition, we are opening up a new field for our image-guided therapies business. Together with our strong portfolio in imaging, digitalization and artificial intelligence, we are creating significant synergies to advance therapy outcomes,” said Bernd Montag, CEO of Siemens Healthineers AG.

“The interplay of exact imaging and robotic-assisted interventions will enhance both the eyes and hands of the physician, metaphorically speaking. With the addition of Corindus to our strong therapies portfolio we sharpen our procedural focus and will grow by expanding precision medicine and improving clinical outcomes. In the future, our digital and artificial intelligence-based tools will help to integrate the aspects of image-guidance and therapy even further,” said Michel Therin, President Advanced Therapies at Siemens Healthineers.

“The collaboration with Siemens Healthineers is a unique opportunity to take our business to the next level and continue our success story. Together we plan to develop next-generation solutions that further improve patient care,” said Mark Toland, President and CEO at Corindus.



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Gold member
More info

More articles about Siemens Healthineers

15 Oct 2019
Siemens Healthineers’ AI-Based Chest CT Software Receives US FDA Clearance
The US Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers that brings artificial intelligence (AI) to computed tomography (CT).
Read More
05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More

Additional news

01 Apr 2020
SymphonyAI Acquires TeraRecon
SymphonyAI Group (Los Altos, CA, USA), an operating group of leading business-to-business artificial intelligence (AI) companies, has acquired TeraRecon (Durham, NC, USA), an advanced visualization and AI solution provider for medical imaging.
Read More
23 Mar 2020
Artificial Intelligence-Based Methods to Cut MRI Read Times Receives USD 250K Grant
 Research to detect and predict blocked arteries and cardiovascular risk using knee MRI images conducted by Chun Yuan, Ph.D., Professor of Radiology and Bioengineering and Vice Chair for Global Affairs at the University of Washington (Seattle, WA, USA) has been recognized and awarded a grant by the American Heart Association’s (AHA) Institute for Precision Cardiovascular Medicine (Dallas, TX, USA).
Read More
23 Mar 2020
Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions
 The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are finding increased acceptance in the emerging Asia region, according to a study by Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider. The study is based on recent findings by IEEE (an Association for Electronic Engineering) that millennial parents are increasingly opting for robotic surgeries for their children in Asia Pacific region. The study also reveals that low availability of robotic surgeries remains a concern.
Read More
19 Mar 2020
Advantech Launches Medical-Grade AVAS-400 Series 4K UHD Video Recorder
 Advantech Co., Ltd. (Taipei, Taiwan), a provider of medical computing platforms and solutions, has launched its AVAS-400 Series medical-grade 4K ultra high-definition (UHD) video recorder aimed at ensuring operating precision. Advantech’s AVAS-400 Series, which includes two models, the AVAS-401 and the AVAS-402, are ideal for surgery centers, operating rooms, and training facilities that use 4K UHD cameras and display monitors for surgical operations and post-surgery reviews and research.
Read More
19 Mar 2020
Artificial Intelligence Helps Cancer Patients Start Radiation Therapy Sooner
 A new study by researchers from UT Southwestern’s Medical Artificial Intelligence and Automation (MAIA) Lab (Dallas, TX, USA) has demonstrated that artificial intelligence (AI) can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.
Read More
18 Mar 2020
Global Radiation Therapy Market to Reach USD 8.6 Billion by 2026 on Back of Product Approvals
 The global radiation therapy market is projected to record a steady growth rate of 5.2% from 2018 to 2026 to reach USD 8.6 billion by 2026, driven by a surge in product approvals, increased expenditure on healthcare, high incidence of cancer, growing preference for non-invasive treatment procedures, technological advancements, and notable research and development activities.
Read More
18 Mar 2020
Global Multiparameter Patient Monitoring Devices Market to Reach USD 6 Billion by 2025
 The global multiparameter patient monitoring devices market is expected to grow at a CAGR of over 4%, or record an incremental growth of around USD 1.32 billion, during the forecast period 2019?2025 to reach USD 6 billion in 2025. These are the latest findings of Arizton (Chicago, IL, USA), a provider of market research solutions.
Read More
17 Mar 2020
AI-based Ultrasound Echo Imaging Software Receives FDA Marketing Authorization
 The US Food and Drug Administration (FDA) has authorized the marketing of a software that uses artificial intelligence (AI) to assist medical professionals in the acquisition of cardiac ultrasound images. The software, Caption Guidance from Caption Health (Brisbane, CA, USA), a medical AI company, uses AI to empower medical professionals without specialized training to perform cardiac ultrasound.
Read More
17 Mar 2020
Global Defibrillators Market Projected to Reach USD 11.7 Billion by 2025
 The global defibrillators market is projected to grow at a CAGR of 3.4% from USD 9.6 billion in 2019 to USD 11.7 billion by 2025, driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. Additionally, the emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for the players in the defibrillators market. However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and lack of awareness about sudden cardiac arrest in the developing countries are expected to hinder the growth of the market during the forecast period.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions